PL430182A1 - 3-nitrogen derivatives of methyl 2,3-dideoxy-D-ribo-hexopyranosides for use as an HIV-1 reverse transcriptase inhibitor - Google Patents

3-nitrogen derivatives of methyl 2,3-dideoxy-D-ribo-hexopyranosides for use as an HIV-1 reverse transcriptase inhibitor

Info

Publication number
PL430182A1
PL430182A1 PL430182A PL43018219A PL430182A1 PL 430182 A1 PL430182 A1 PL 430182A1 PL 430182 A PL430182 A PL 430182A PL 43018219 A PL43018219 A PL 43018219A PL 430182 A1 PL430182 A1 PL 430182A1
Authority
PL
Poland
Prior art keywords
dideoxy
methyl
ribo
hiv
reverse transcriptase
Prior art date
Application number
PL430182A
Other languages
Polish (pl)
Other versions
PL240353B1 (en
Inventor
Aleksandra Małgorzata Dąbrowska
Rajmund Kaźmierkiewicz
Anna Maria Barabaś
Grzegorz Aleksander Nowiak
Inga Blanka Jamrożek
Mariusz Makowski
Original Assignee
Uniwersytet Gdański
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Gdański filed Critical Uniwersytet Gdański
Priority to PL430182A priority Critical patent/PL240353B1/en
Publication of PL430182A1 publication Critical patent/PL430182A1/en
Publication of PL240353B1 publication Critical patent/PL240353B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem wynalazku jest para anomerów 3-azydo-2,3-dideoksy-D-rybo-heksopiranozydów metylu i para anomerów 3-amino-2,3-dideoksy-D-rybo-heksopiranozydów metylu do zastosowania jako nienukleozydowy (tj. zawierający jedynie glikon i grupę metoksylową jako aglikon) inhibitor odwrotnej transkryptazy wirusa HIV-1.The invention relates to a pair of methyl 3-azido-2,3-dideoxy-D-ribo-hexopyranoside anomers and a pair of methyl 3-amino-2,3-dideoxy-D-ribohexopyranoside anomers for use as a non-nucleoside (i.e. and a methoxy group as an aglycone) HIV-1 reverse transcriptase inhibitor.

PL430182A 2019-06-07 2019-06-07 3-nitrogen derivatives of methyl 2,3-dideoxy-D-ribo-hexopyranosides for use as an HIV-1 reverse transcriptase inhibitor PL240353B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL430182A PL240353B1 (en) 2019-06-07 2019-06-07 3-nitrogen derivatives of methyl 2,3-dideoxy-D-ribo-hexopyranosides for use as an HIV-1 reverse transcriptase inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL430182A PL240353B1 (en) 2019-06-07 2019-06-07 3-nitrogen derivatives of methyl 2,3-dideoxy-D-ribo-hexopyranosides for use as an HIV-1 reverse transcriptase inhibitor

Publications (2)

Publication Number Publication Date
PL430182A1 true PL430182A1 (en) 2020-12-14
PL240353B1 PL240353B1 (en) 2022-03-21

Family

ID=73727738

Family Applications (1)

Application Number Title Priority Date Filing Date
PL430182A PL240353B1 (en) 2019-06-07 2019-06-07 3-nitrogen derivatives of methyl 2,3-dideoxy-D-ribo-hexopyranosides for use as an HIV-1 reverse transcriptase inhibitor

Country Status (1)

Country Link
PL (1) PL240353B1 (en)

Also Published As

Publication number Publication date
PL240353B1 (en) 2022-03-21

Similar Documents

Publication Publication Date Title
CL2023000555A1 (en) Compounds and methods for the treatment of viral infections
CL2021003191A1 (en) Tead inhibitors and uses thereof
CO2021013339A2 (en) Stat degraders and their uses
CO2022010098A2 (en) Mutant kras protein inhibitors
MX2022007085A (en) NANOEMULSION FOR ORAL USE.
CO2022008662A2 (en) Brand degraders and their uses
CY1126067T1 (en) FUSIONED PYROLINES THAT ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30) INHIBITORS
BR112021023024A2 (en) Antibody against claudin 18a2 and its use
EA201892007A1 (en) 3-DESOXY DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS ON ITS BASIS
UY30846A1 (en) OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES
MX418110B (en) SOLID DISPERSIONS AND PHARMACEUTICAL COMPOSITIONS COMPRISING A SUBSTITUTED INDANE AND METHODS FOR THEIR PREPARATION AND USE
CL2021001536A1 (en) 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising them
CL2004000366A1 (en) USE OF A COMBINATION OF A QUINASA P38 INHIBITING DERIVED COMPOUND OF PIRAZOL, AND AN ACE INHIBITOR TO TREAT RENAL DYSFUNCTION, CARDIOVASCULAR AND VASCULAR DISEASE, RETINOPATHY, NEUROPATIA, EDOTEL, INSOTUNATIO OPINION.
ECSP21082195A (en) SOLID FORMS OF A GLYT1 INHIBITOR
CR20220187A (en) SOLID STATE CRYSTALLINE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODULATOR
CO2026004176A2 (en) stat6 degraders and their uses
UY38233A (en) INHIBITING AGENTS FOR BRUTON TYROSINE KINASE
MX2020008125A (en) COMPOSITIONS COMPRISING BERBERINE.
CO2021007172A2 (en) Crystalline salts of a plasma kallikrein inhibitor
MX2023010529A (en) COMPOSITIONS FOR ORAL CARE THAT INCLUDE HOPS AND SWEETENER.
MX2022000654A (en) FLUORESCENT SYSTEMS FOR BIOLOGICAL IMAGES AND THEIR USES.
AR114270A1 (en) 4-METHYLDIHYDROPYRIMIDINONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
BR112022000155A2 (en) Inhibitory composition of the pi4kiiia micromolecule, its method of preparation, and its use
MX2025006649A (en) Solid forms of a sgc activator
BR112022016359A2 (en) CRYSTALLINE FORMS OF A PHARMACEUTICAL COMPOUND